Scott A. Michaels is a notable inventor based in Burlington, MA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of subcutaneous administration of furosemide. With a total of 4 patents to his name, Michaels continues to push the boundaries of innovation in medicine.

Latest Patents

Michaels' latest patents focus on liquid pharmaceutical formulations of furosemide. These formulations include a molar excess of tris(hydroxymethyl)aminomethane to furosemide, with a pH range of 7 to 8.5. Additionally, the concentration of tris(hydroxymethyl)aminomethane is greater than or equal to about 50 mM. The teachings presented in these patents aim to improve the stability of liquid pharmaceutical formulations, enhancing their suitability for subcutaneous administration or delivery.

Career Highlights

Scott A. Michaels is currently associated with ScPharmaceuticals Inc., where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing the formulation of medications that can be administered more effectively to patients.

Collaborations

Michaels has collaborated with notable colleagues in his field, including Pieter Muntendam and Glenn R. Larsen. These partnerships have contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Scott A. Michaels stands out as a dedicated inventor in the pharmaceutical industry, with a focus on improving drug formulations for better patient outcomes. His contributions continue to shape the future of medical treatments.

This text is generated by artificial intelligence and may not be accurate.